Manina Medtech

The company develops Seedchrony, a non-invasive medical device that uses artificial intelligence and biomarker data to assess uterine readiness for embryo transfer in real-time. The technology aims to increase IVF pregnancy rates by helping clinicians identify the optimal window for endometrial receptivity without the need for a biopsy. The product is designed for fertility clinics and medical professionals performing assisted reproduction procedures.